Turkey has started testing plasma therapy as a possible treatment for the coronavirus disease, Turkish Red Crescent Society President Kerem Kinik said on Tuesday.
"We are waiting for blood donations from all the heroes who defeated the coronavirus 14 days after their discharge from hospitals, in order to save the lives of other patients," Kinik said, as quoted by the Turkish state broadcaster TRT.
According to Kinik, every person who has recovered from COVID-19 can donate blood three times a week.
Kursat Demir, a recently recovered Turkish doctor, became the first plasma donor in the country, TRT reported. Demir donated blood at the Red Crescent's facility.
The plasma of recovered patients contains antibodies that can be transfused into other patients who have contracted the disease.
Turkey has so far confirmed 30,217 COVID-19 cases and 649 deaths from coronavirus-related complications.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
